Efficacy and safety of CD19 chimeric antigen receptor T cells in the treatment of 11 patients with relapsed/refractory B-cell lymphoma: a single-center study - Huang, Chen; Wu, Lili; Liu, Ruixia; Li, Weijing; Li, Zheng; Li, Jianqiang; Liu, Lihong; Shan, Baoen (Annals of Translational Medicine, 2020)